PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
PDS Biotechnology Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.92−0.21 (-18.89%)
Close on Oct 19, 2026
- Market cap
- $51.01M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$31.54MFY2025